Clinical Trial Update: A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial investigates autologous regulatory T cell infusion in combination with everolimus (Zortress) for kidney transplant recipients with end-sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Zortress (everolimus)

Snippet

Sponsor: Roberto Gedaly | Conditions: End Stage Renal Disease, Kidney Transplant | EARLY_Phase 1 | Status: COMPLETED